Results 241 to 250 of about 1,468,006 (309)

Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals. [PDF]

Contemp Clin Trials Commun
Kasim A, Anastasiou M, Loizou E, Dimakakos A, Georganaki M, Mourelatos I, Karelis P, Esposito M, Zhou H, Chen TT, Skaltsas D, Stockman P.   +11 more
europepmc   +1 more source

Practical Pharmacokinetic-Pharmacodynamic Models in Oncology. [PDF]

Pharmaceutics
Guan S, Tu MJ, Yu AM.
europepmc   +1 more source

Nano-Engineered Delivery of the Pro-Apoptotic KLA Peptide: Strategies, Synergies, and Future Directions. [PDF]

Biomolecules
Cho Y, Kim HG, Oh ET.
europepmc   +1 more source

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer. [PDF]

Elife
Armand J, Kim S, Kim K, Son E, Kim M, Kalinsky K, Yang HW.   +6 more
europepmc   +1 more source

Antiseizure Effects of Cannabidiol in Combination With Cannabigerol in the Maximal Electroshock Seizure Model. [PDF]

Basic Clin Pharmacol Toxicol
Zhou HZ, Scott BW, Oleksak YI, Burnham WM.   +3 more
europepmc   +1 more source

Drug combinations in topical therapy.

The Western journal of medicine, 2010
openaire   +1 more source